Last reviewed · How we verify

NCT05355792

Multicenter Study to Evaluate the Clinical Outcome of the OmniTaper EV Implant in Single Tooth Restorations

Active, enrolled NA Last updated 17 February 2026
What this trial tests

NA trial testing OmniTaper EV implants in Jaw, Edentulous in 139 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
22 September 2022
Primary endpoint
30 November 2028
31 January 2029

Quick facts

Lead sponsorDentsply Sirona Implants and Consumables
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment139
Start date22 September 2022
Primary completion30 November 2028
Estimated completion31 January 2029
Sites6 locations across United Kingdom, Switzerland, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Dentsply Sirona Implants and Consumables — full company profile →

Who can join

Adults 18 to 75, any sex, with Jaw, Edentulous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study, funded by the company Dentsply Sirona, is being carried out to see if the newly developed tooth implant "OmniTaper EV" is safe, effective and functions as intended when replacing a lost or removed tooth. The OmniTaper EV implant is a further development of existing dental implants. It is made of titanium, a metal that is well tolerated by the human body, which has been successfully used in dental implants for more than 40 years. All components used in this study are available on the market, are CE-marked and will be used according to intended use and approved instructions. The study involves at 11 planned clinic visits including follow-up visits 6 months and annually until 5 years after installation of the permanent crown. after over a period of about five and a half years. The treatment method and healing period may vary depending on the individual case and treatment plan and additional visits may therefore need to be scheduled. The visits and procedures are the same as standard of care and no procedures will be done just for purpose of research. The study aims to recruit about 137 men and women from six clinics across Europe (Germany, UK and Switzerland) and participants can only receive one study implant each. Participation is entirely voluntary and participants can choose to withdraw from the study at any time, without giving a reason. The decision to decline or withdraw participation will not affect participants future treatment or care

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Dentsply Sirona Implants and Consumables trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05355792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing